Treatment with the inhibitor in combination with a LAG-3 blocking antibody produced a cooperative effect, resulting in increased tumor growth suppression, as well as increased levels of granzyme B and IFN-γ in CD8 + T lymphocytes in murine melanoma models [61]. The gene discussed is LAG3; the disease is melanoma.